SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-018427
Filing Date
2024-06-28
Accepted
2024-06-28 16:30:16
Documents
1
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 form3-06282024_080611.html 3  
1 form3-06282024_080611.xml 3 1682
  Complete submission text file 0001415889-24-018427.txt   3188
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNITED THERAPEUTICS 1000 SPRING STREET SILVER SPRING MD 20910
Business Address
MALCOLM JAN (Reporting) CIK: 0002028640 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26301 | Film No.: 241086152